| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Dicerna Pharmaceuticals, Inc. Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXCTM and GalXC-PlusTM RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with … Type: | 16 | 0 | 5 | 160 |
 |  Medherant Limited Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the … Type: | 2 | 0 | 1 | 17 |
 | Stevanato Group Founded in 1949, Stevanato Group is one of the world's largest providers of integrated containment and delivery solutions for the biopharmaceutical industry. From the beginning, the Group has developed its own glass forming technology to ensure quality of the highest standards. The Group includes a wide range of skills dedicated to serving the biopharmaceutical and diagnostic industry. It offers glass containers with its historic Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, up to inspection, assembly and packaging machines. The Group also provides analytical services and tests that study the interaction between … Type: | 0 | 0 | 0 | 1,963 |
 | Chiesi España [Automatic translation follows] As a B Corp company, we are driven by the #purpose of improving the quality of #people's lives. #SomosChiesi Chiesi is an international research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases and specialty care. Our mission is to improve people's quality of life and act responsibly for the benefit of the community and the environment. By changing its legal status to Charitable Corporation in Italy, the US and France, Chiesi's commitment to creating shared value for society as a whole is legally binding and central to the company's decision making. … Type: | 15 | 1 | 16 | 257 |
 | MSD España [Automatic translation follows] We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster … Type: | 7 | 1 | 2 | 374 |
 | HealthEconomics.com | A Scientist.com Company CONNECTED COMMUNITY(tm) for HEOR, Market Access, Real World Evidence, and Value demonstration global decision-makers. HealthEconomics.com is the world’s largest digital CONNECTED COMMUNITYTM that provides a single global link to the value, evidence, and access community. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect with key customers world-wide. Our 25,000 readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and Market Access. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com to connect … | 3 | 0 | 4 | 2 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | Vitusapotek [Automatic translation follows] Together on the way to better health Vitusapotek is a nationwide pharmacy chain with 300 pharmacies and more than 3,000 employees. Vitusapotek is owned by Norsk Medisinaldepot AS (NMD), one of Norway's largest suppliers of pharmaceuticals and health-related products. NMD's second chain concept, Ditt Apotek, consists of collaborative pharmacies and currently has over 60 pharmacies. Our central warehouse and administration is located at Alna in Oslo, while large parts of northern Norway are served from our warehouse in Harstad. Customers are at the center of everything we do. We want to provide the necessary help to cure … Type: | 2 | 1 | 1 | 1,267 |
 | La Renon Healthcare Pvt.Ltd. One of the top 50 Pharma companies of India, La Renon is a new century dynamic company established in the year 2007 in Ahmedabad. 'La Renon' is created out of a passion to become a global healthcare company by offering World-class quality pharmaceutical products and services for various critical illnesses and diseases. The major segments that La Renon caters to are Nephrology, Critical Care, Neurological Disorders, Urology, Gastroenterology, Respiratory, Cardio Metabolic and Gynaecology.. La Renon has also proliferated into major South East Asian, African and CIS countries. Soon it shall be making a mark across the globe living up to … Type: | 0 | 0 | 0 | 880 |
 | Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: | 9 | 5 | 3 | 221 |
 | PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: | 0 | 0 | 0 | 10 |
 | NovAliX NovAliX is a preclinical drug discovery-focused CRO NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand … Type: | 27 | 4 | 25 | 379 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 6 | 4 | 2 | 154 |
 | Cyclopharma Pour répondre aux enjeux de la médecine personnalisée, nous développons des solutions d’imagerie moléculaire innovantes pour l’aide au diagnostic et le suivi thérapeutique en oncologie, neurologie, cardiologie afin d’améliorer la qualité de vie des patients, la sécurité et l’efficacité thérapeutiques tout en réduisant les coûts. To meet the challenges of personalized medecine, we are developing molecular imaging solutions in oncology, neurology, cardiology which improve patients' quality of life, security and therapy efficiency, while reducing costs. radiopharmacy, healthcare, and oncology Type: | 1 | 0 | 1 | 26 |
 | Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: | 6 | 2 | 4 | 8 |
 | Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: | 2 | 2 | 1 | 210 |
 |  Ananda Developments Plc AQSE-listed company whose ambition is to be a leading provider of cannabinoid medicines for chronic pain conditions. Developer of cannabinoid-based medicines for the treatment of complex, chronic, inflammatory pain conditions. Patent pending formulation being used in two fully funded Phase II RCTs at Edinburgh University. Sale of two cannabidiol formulations through UK based medical cannabis pharmacy networks. Please contact for more info. research, science, and medicalcannabis | 0 | 0 | 0 | 8 |
 | Intervacc AB A new generation of vaccines based on fusions of recombinant proteins A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile. Veterinary, Vaccines, Animal Health, Biotech, Recombinant Vaccines, Veterinary Products, Microbiology, Wholesale, and Research and Development Type: | 0 | 0 | 0 | 12 |
 | Qualifyze Enhancing healthcare supply chains with data-driven compliance solutions, worldwide. Since Qualifyze's inception in 2019, we have been a driving force behind pharmaceutical excellence. We enhance connections between manufacturers, suppliers, and global quality professionals through our digital solutions and data insights, with the aim of creating a healthier tomorrow. We empower our 1000+ healthcare and pharma clients to achieve and maintain the highest quality standards across their supply chain. This is accomplished by allowing them to efficiently track, monitor, and forecast quality and sustainability compliance. Enabled by the world's largest GxP audit database, our solutions efficiently centralize compliance, quality data, and … Type: | 0 | 0 | 0 | 166 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 4 | 2 | 2 | 8 |
 | Pharmica Making Pharmacy Easy Pharmica is an award-winning online pharmacy in the UK, rated 4.9/5 across more than 180,000 reviews and ranked #1 on Trustpilot in the Online Prescription Medication and Medical Supply Store categories. Pharmica is a fully regulated pharmacy and dispenses a broad range of MHRA-approved treatments quickly and discreetly from its Central London location. Pharmica has assisted more than 1.2 million people across the UK through a patient-centric philosophy and the use of cutting-edge technology to provide a fast, safe, and confidential online pharmacy experience. | 0 | 0 | 0 | 24 |
 | COFARES [Automatic translation follows] Health moves us Cofares is a company established with exclusively pharmaceutical capital that operates with the corporate formula of a cooperative. With a turnover in 2012 of more than 2.5 billion euros, it is the leading medicine distribution company in Spain. Medication distribution Type: | 4 | 1 | 4 | 1,492 |
 | Helsinn Group Building quality cancer care together Welcome to Helsinn’s LinkedIn page. This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world … Type: | 0 | 0 | 0 | 397 |
 | Nicox Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development Type: | 1 | 1 | 0 | 55 |
 | Teva Santé [Automatic translation follows] Who is Teva Health? Present in more than 60 countries, the leading producer of active ingredients for the pharmaceutical industry, Teva is one of the largest pharmaceutical laboratories in the world. Its range of medicines, generic or not, allows the treatment of more than 120 pathologies. In France, its medicines concern one in 12 prescriptions. But Teva's involvement goes well beyond just medicine. Its action is part of commitments in favor of patients, doctors, pharmacists and caregivers. With regard to the latter, the laboratory is particularly committed to helping them identify themselves, understand and master their role, … Type: | 12 | 1 | 9 | 261 |
 |  InFlectis BioScience Developpment of small molecules to prolong the protective effect of the Integrated Stress Response InFlectis BioScience is a private clinical-stage company aiming to target and modulate interactions between proteins involved in key human pathophysiological processes. The company is developing IFB-088 (INN: icerguastat), which specifically targets the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of diseases affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation. … Type: | 2 | 2 | 0 | 10 |
 | CREAPHARM BIO&PHARMA Contract Packaging & Logistics Organization Biostorage: Securing Biobanking of precious biological samples // Clinical Supply: Managing Clinical Trial Material with agility // Commercial Packaging: Taking up packing and repacking challenges Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP Sourcing and Importation, and Biological sampling kit production | 11 | 2 | 7 | 137 |
 | SOM Biotech Biopharmaceutical company focused on the accelerated development of drugs for orphan indications through AI technology SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting … Type: | 2 | 1 | 1 | 15 |
 | Santhera Pharmaceuticals We are dedicated to developing medicines to meet the needs of patients living with rare diseases. Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need. The Company has an exclusive license from ReveraGen for all indications worldwide to AGAMREE® (vamorolone), a dissociative steroid with novel mode of action, which was investigated in a pivotal study in patients with Duchenne muscular dystrophy (DMD) as an alternative to standard corticosteroids. AGAMREE for the treatment of DMD is approved in the U.S. by the … Type: | 0 | 0 | 0 | 74 |
 | Farmacias Cruz Verde Chile [Automatic translation follows] The Low Price Pharmacy We are the leading pharmacy chain in Chile, with more than 30 years in the market. Our commitment is to provide access to quality medications and hygiene, personal care, beauty and well-being products at affordable prices, which we reinforce every day through the benefits of the Cruz Verde Club. We have more than 700 stores and 6,300 workers in Chile, reaching isolated areas such as Easter Island and Cerro Sombrero. We even have mobile pharmacies to provide access and coverage of medicines in remote areas of the north and south of Chile. Since … Type: | 1 | 0 | 1 | 3,219 |
 | POLEPHARMA [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Polepharma structures the French (bio)pharmaceutical industrial sector and has been supporting its transformation for 20 years. Polepharma has become the first pharmaceutical industrial cooperation in Europe, between areas of excellence and players in the sector: 400+ members, 60% of production & 70k jobs in France. Established in 5 territories (Centre-Val de Loire, Ile-de-France, Normandy, Occitanie, Nouvelle-Aquitaine), Polepharma supports its members throughout France. These are laboratories, suppliers, schools, collectives, experts, talents who want to make France the best place in the world to develop & produce medicines, that is to say cutting-edge, virtuous, … Type: | 48 | 27 | 27 | 28 |
 | 800-Pharmacy Your Pharmacy, Everywhere. 800-Pharmacy is the first licensed and approved app for the best health products delivery service in the United Arab Emirates. Type: | 0 | 0 | 0 | 72 |
 | Medrise Studio Driving healthcare's digital evolution with Web3. Driving healthcare's digital evolution with Web3. From the genesis block to groundbreaking solutions, we're your bridge to the decentralized era. blockchain, digital health, pharmaceuticals, consulting, technology, artificial intelligence, and patients Type: | 8 | 1 | 4 | 5 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 3 | 2 | 3 | 116 |
 | PhinC Development 15 ans de modélisation en pharmacologie appliquée au développement des candidats-médicaments PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the regulatory authorities … Type: | 6 | 2 | 5 | 16 |
 | Daiichi Sankyo UK Daiichi Sankyo UK is a pharmaceutical company with corporate origins in Japan. Daiichi Sankyo UK is a pharmaceutical company with corporate origins in Japan. We create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology. Our company was founded in 2006 through the merger of Japanese companies Daiichi and Sankyo in Europe. With a rich legacy of scientific expertise dating back more than 100 years, we are the pioneer behind leading pharmaceuticals that have contributed to the improvement of countless lives across the world. Our mission is to … Type: | 2 | 0 | 2 | 147 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 18 |
 | First Wave BioPharma, Inc. Targeted, Non-Systemic Therapies for Gastrointestinal Diseases First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. First Wave’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis … Type: | 1 | 0 | 1 | 12 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 7 |
 | Boehringer Ingelheim (schweiz) Gmbh Boehringer Ingelheim (schweiz) Gmbh is a pharmaceuticals company based out of DUFOURSTRASSE 54, Basel, Switzerland. Type: | 1 | 1 | 0 | 7 |
 |  MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company A Swiss Microbiota biotherapeutics and Vaccines company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: 1. ApyraVax® with the lead indication of Clostridium difficile infection 2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and modulator of antibiotic-induced disbyosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. The company is looking for seed funding … Type: | 1 | 1 | 0 | 1 |
 | PharmaZell Group We supply the world with active pharmaceutical ingredients. One Group – Three Offerings The PharmaZell Group is made up of three core brands – PharmaZell, Farmabios and PharmaChol who supply the pharmaceutical industry with Active Pharmaceutical Ingredients and natural source materials. The Group operates production facilities in Germany, Italy and India and enables its companies to secure the industry’s supply chain as trusted drug substance suppliers. Over 900 people work for the PharmaZell Group worldwide. Key Group Facts: - More than €170 million revenue in 2018 - Superb annual growth rate over the last decade - A strong and competitive … Type: | 1 | 1 | 0 | 40 |
 | Diaceutics PLC Better Testing, Better Treatment At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®. DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Personalized medicine planning and corporate strategy, Comprehensive commercial planning in personalized medicine, Optimizing return on investment in personalized medicine, Leveraging diagnostics to enhance value in personalized medicine, Understanding … Type: | 4 | 2 | 1 | 200 |
 | Grupo Menarini España [Automatic translation follows] We are a people-focused pharmaceutical company. Grupo Menarini's desire is to offer new and better medicines and health care products every day. With an extensive international presence, Grupo Menarini employs more than 16,000 people around the world, of which more than 600 make up the GRUPO MENARINI ESPAÑA workforce. Our HUMAN TEAM, after an adequate selection and training process, contributes with its effort and commitment to making our future objectives possible. Our CORPORATE VALUES reflect the character of Menarini and that of its people: integrity, ethics, commitment to quality and the environment and strict compliance with current … Type: | 3 | 1 | 0 | 516 |
 | OCP Répartition [Automatic translation follows] Leader & Reference for the Pharmacy of Tomorrow OCP at the heart of the health chain OCP is both the leader and the historical referent (1924) of pharmaceutical distribution in France. By providing pharmaceutical logistics and efficient services, OCP is the essential link between laboratories and pharmacists. Every day we contribute to better health. With a territorial network of 41 establishments in France, OCP holds nearly 32% market share and distributes 2 million boxes of medications every day to 16,000 customer pharmacies (including 2,000 hospital pharmacies), from a range of 36,000 references available. OCP is the first … Type: | 14 | 3 | 11 | 1,359 |
 | Creativ-Ceutical Creativ-Ceutical provides strategic pricing, market access and health economics consulting in life sciences. We provide both the strategic advice and the technical services to deliver results that meet your expectations. We have broad experience in the areas of central nervous system (CNS), oncology, vaccines, metabolic/cardiovascular diseases, and rare diseases. These are complex and developing fields, where treatment paradigms are in constant evolution and where clinical and economic issues require rigorous analysis to determine the best therapeutic choices. This experience allows us to address the most complex challenges and to anticipate pricing and market access issues that will arise in other … Type: | 0 | 0 | 0 | 83 |
 | Five Alarm Bio Limited Boosting the body's ability to defend against the damage of aging Five Alarm Bio is a drug discovery company based in Cambridge, UK focusing on novel approaches to anti-aging, with broad potential therapeutic application. We are researching therapeutics that boost the body's ability to defend against the damage of aging. Type: | 0 | 0 | 0 | 4 |
 | RHNANOPHARMA RH/Nanopharma is a Biopharma company dedicated to treating, preventing, slowing and reversing inflammatory diseases. | 0 | 0 | 0 | N/A |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 33 | 12 | 25 | 66 |
 | Versantis Multiorgan support for rare pediatric and acute liver diseases Versantis is a clinical-stage pharmaceutical company developing a new generation of orphan medicines to revolutionize the care of patients with liver and rare pediatric diseases. We address the unmet medical needs in emergency care. Our mission is to support acute decompensations of cirrhosis and to save infants born with rare genetic disorders. Hepatology, Hyperammonemia, Metabolic disease, Liver diseases, and Gastroenterology | 0 | 0 | 0 | 2 |
 | Molecule AG A decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs We propel science from lab to life, fueled by a community committed to human progress. blockchain, pharma, health, science, biotech, and Token Bonding Curves Type: | 5 | 0 | 2 | 31 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech Type: | 15 | 4 | 8 | 10 |
 | Galmed Pharmaceuticals Ltd. A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, AramcholTM, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com Type: | 1 | 1 | 0 | 11 |
 | Palette Dentals Making Smiles Equal and Healthier Palette is a research project developing new dental care products that would offer a better solution for your health in contrast to the existing ones and provide the necessary dental protection to every family in the world, inclusive of these who can’t afford it yet. | 1 | 0 | 1 | 1 |
 | Antera 3D® Skin Analysis As It Should Be Antera 3D® can analyse wrinkles, texture, volumes, skin colour, redness and pigmentation. These features help clinicians to make the most out of all the treatments they offer. Type: | 0 | 0 | 0 | N/A |
 | inven Some things cannot be comprised especially quality of life saving drugs, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That`s why, we at Inven, are committed to apply science and our resources, for providing most innovative and quality products. We strive to provide access to safe, effective and affordable medicines to the people who need them. With a strong research oriented work culture, state-of-the-art production facility and end-to-end product development capabilities - Inven is recognized as a leading, ISO 9001-2000 and WHO GMP certified, IV fluid manufacturer in the international and domestic … Type: | 2 | 1 | 0 | 31 |
 | eXYSTAT [Automatic translation follows] Quality Honesty Transparency Conviviality Simplicity eXYSTAT is a company of 2 partners created in October 2013 to offer players in the world of health expertise in the field of biometrics for clinical studies. Our ambition is to offer expertise in the field of biometrics and clinical studies that we believe differentiates itself from the existing offering in France at the moment. Our technical expertise, the result of our complementary experiences, covers the areas of clinical trials and epidemiological studies. Within subsidiaries, laboratory parent companies, biotechnology companies and service companies (CROs), our careers have also led us to … Type: | 1 | 0 | 1 | 19 |
 | CYBERNANO Optimize your product development, Quality by Design for all ! CYBERNANO aims to support pharmaceutical, biotech and medtech companies in the Quality-by-Design (QbD) process. The use of QbD is necessary in these high accuracy industries to predict and avoid risks from the early stage of an innovant project. In order to democratize the QbD approach, which requires a lot of effort and expertise, CYBERNANO offers a QbD semi-automated* SaaS platform : « easyQBD ». *(an expert perspective combined to the efficacy of the platform) CYBERNANO a pour vocation d’accompagner les entreprises des secteurs pharmaceutiques, biotechnologiques et des technologies médicales dans … Type: | 8 | 0 | 7 | 6 |
 | STANIPHARM Expert services in supercritical CO2 and nanomedicines for the life science industry StaniPharm is a Contract Development and Manufacturing Organization (CDMO). Pioneers in supercritical CO2 technologies, we operate a state-of-the-art facility and provide the life science industry with flexible development and GMP manufacturing services. We move your products from idea to market: botanical extracts, challenging polymers and lipids, nanomedicines, tailored drug particles. Keywords : nanoparticles, medicinal cannabis, particle and crystal engineering, crystallization, polymers, lipids, supercritical fluids, purification, formulation, impregnation, sterilization, GMP manufacturing, poorly soluble drugs, polymorphism, CDMO drug delivery, supercritical fluids, formulation, nanoparticles, GMP manufacturing, poorly soluble drugs, sterilization, impregnation, … Type: | 2 | 2 | 0 | 11 |
 | AGV Discovery [Automatic translation follows] AGV Discovery offers services in chemistry, cell biology, in vitro screening, rational drug design, outsourcing and consultancy. AGV Discovery is a pharmaceutical company that specializes in the rational design and early development of drug candidates. Type: | 0 | 0 | 0 | 4 |
 | SEQENS Our science for your future SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies. … Type: | 34 | 8 | 28 | 1,276 |
 | URGO Group [Automatic translation follows] Invent & Care The URGO Group is committed every day to changing the lives of patients, by putting science at the service of therapeutic progress. It supports healthcare professionals to promote best care practices. 2 PROFESSIONS URGO MEDICAL Faced with the explosion of chronic diseases such as diabetes, Urgo Medical responds to a growing need for care of serious and disabling wounds. We help patients heal better, faster, by developing solutions that have proven their superiority in clinical studies. HEALTHCARE In order to allow everyone to become an actor in their health, our Urgo Healthcare, Juva Santé … Type: | 22 | 7 | 9 | 2,635 |
 | Unither Pharmaceuticals A world-leading pharmaceutical contract development manufacturing organization (CDMO). Unither Pharmaceuticals, with 8 manufacturing plants (France, USA, Brazil and China) 4 commercial offices and 1 R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing. Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Multidoses with and without preservative, Pharmaceuticals bottles, Suppositories and Pessaries, etc. Our products are sold in more than 100 countries for an annual turnover of 371 million euros. Our vision is to be recognized for making affordable healthcare solutions that improve … Type: | 15 | 5 | 9 | 1,267 |
 | Entourage Health Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s … Type: | 1 | 0 | 1 | 125 |
 | Tilray Brands, Inc. Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and … Type: | 2 | 0 | 2 | 970 |
 | MORSE Consulting Inc. Deciphering pharmaceutical market access signals to create reimbursement success. Established in January 2017, Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc’s vision is to be a leader in strategic pharmaceutical reimbursement consulting with a reputation for honesty, integrity, and collaboration. With a presence in both Toronto and Ottawa, MORSE seeks to effectively understand our client’s challenges and develop viable strategies to navigate the market access landscape. MORSE offers a range of services related to both negotiation and reimbursement strategies. Reimbursement Risk Appraisal, Market Access Appraisal, Advisory Boards, Private Payer PLA Strategy, PLA Seminar, Negotiation "Revitalization", Ongoing Strategic Advice, Reimbursement … | 1 | 0 | 1 | 15 |
 | Abdi Ibrahim Pharmaceuticals İşimiz İyileştirmek Abdi İbrahim, Turkish pharmaceutical industry leader, was founded in 1912 in Küçükmustafapaşa, Istanbul at a small pharmacy, by Pharmacist Abdi Nadir İbrahim Bey who had started the “healing” journey. Abdi İbrahim has the largest product portfolio in the sector, with nearly 250 brands and more than 500 products which it develops itself as well as working with 30 licensors. With a powerful vision, dynamic structure and contemporary outlook, Abdi İbrahim has been the leader of Turkey’s Pharmaceutical Industry since 2002. Today, Abdi İbrahim, which operates in 17 countries outside Turkey, exports to more than 70 countries ranging from … Type: | 4 | 2 | 0 | 4,384 |
 | MediPharm Labs MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, … Type: | 0 | 0 | 0 | 146 |
 | DanCann Pharma A/S - a biopharmaceutical company powered by cannabinoids DanCann Pharma - a biopharmaceutical company powered by cannabinoids | 0 | 0 | 0 | 9 |
 | Galventa AG Empower people to perform every day at their best – from the very moment they wake up. We are on a mission to help you to synchronise your circadian rhythm to improve sleep and waking-up through the development of innovative and clinically tested galenic platform technologies. Our first galenic formulation is based on our own life story: We, the founders, find it difficult to get up in the morning and are so-called night owls, who are more efficient in the evening or even at night. In countless situations however, we are required to perform well in the early hours of … Type: | 0 | 0 | 0 | 8 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 39 |
 | PureIMS 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery PureIMS is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops®. The focus is on the treatment of systemic and respiratory diseases with significant unmet medical need. The company’s leadership team consists of seasoned life sciences executives who bring long-lasting and complementary experience in leading drug development, addressing applicable scientific issues and pursuing commercial and business development & licensing opportunities. They obtained their experience in leading positions with mid-size and top-5 global … Type: | 0 | 0 | 0 | 10 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 6 | 0 | 0 | 59 |
 | Iconovo AB We bring inhalation expertise to your business Iconovo is a leading Swedish CDMO company, offering innovative and effective inhalation platforms to the international pharmaceutical industry. We have several types of patented dry powder inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine. Our strength is our inhouse capabilities with full control over both device development and formulation, meaning less risk and faster time to market. Device development, DPI, and Inhalation | 2 | 1 | 2 | 43 |
 | SOMAÍ Pharmaceuticals We Craft Care At SOMAÍ, we are on a journey to build a leading global brand with the most robust portfolio of innovative cannabis-based therapeutics. We envision a world where people live healthy lifestyles empowered by natural cannabis medicine. Our company is dedicated to formulating innovative cannabis-based products to ensure a healthy and comfortable life. For that, we create a wide variety of medications for chronic patients and different conditions. We aim to design calm and satisfactory experience of administering, prescribing and purchasing cannabis-based medicine. SOMAÍ Pharmaceuticals is an EU-GMP European pharmaceutical and biotech company centered on manufacturing in Lisbon, … Type: | 0 | 0 | 0 | 40 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action. It is demonstrated that one endogenous protease called tissue plasminogen activator (tPA) is implicated in the pathophysiology of neurological diseases such as multiple sclerosis, Parkinson’s disease, stroke and other neurodegenerative disorders through its overexpression and binding to NMDA receptors (NMDAr) present on vascular endothelial cells and regulating the blood brain barrier (BBB) function / … Type: | 13 | 4 | 8 | 12 |
 | Laboratoire Deterlub - DermoFluide 🇫🇷 [Automatic translation follows] Our ISO 9001 laboratory innovates and formulates your daily life The DETERLUB laboratory since 1979, ISO 9001 certified since 2003 located between Cannes and Grasse (Alpes-Maritimes, South of France). OUR MISSION Design resolutely original products, respectful of the needs of our users and concerned about our environment. OUR OBJECTIVE Communicate on the New Horizons of Shaving Protection. OUR VALUES “Never doubt that a small group of conscious and committed individuals can change the World. This is how it has always happened” Margaret Mead American anthropologist (1961-1978) People are at the heart of our Strategy INNOVATION The Dermofluide … Type: | 1 | 0 | 1 | 2 |
 | Zeta Farmaceutici Group [Automatic translation follows] Pharmaceuticals and cosmetics: two great Italian traditions. We renew them every day. Zeta Farmaceutici Group is an Italian industrial reality made up of a group of companies specialized in the development, production and distribution of drugs, medical devices, cosmetics, food supplements, biocides. 1. Production and marketing of products with own brands. Our brands are present in 10,000 pharmacies and parapharmacies, with widespread distribution throughout Italy. 2. Contract manufacturing. Industrial partnership with national and international companies and groups. Our brands. Euphidra. Make up, dermoscomesis, hair coloring, personal hygiene. Amido Mio. The rice starch line to cleanse and protect … Type: | 0 | 0 | 0 | 133 |
 | Gilbert Good health starts with you Since 1904, Gilbert, a French industrial group, has been operating in the fields of pharmaceuticals, cosmetics, hygiene, CDMO and spas & institutes, in order to offer health solutions that respect human and his environment. . With a portfolio of nearly 50 brands - including the Laboratoires Gilbert brand - exported to 86 countries, the Gilbert group occupies leading positions in the fields of health, and in particular in France in the field of baby products for which he is number 1 in pharmacy sales. Gilbert employs more than 1,000 people in its laboratories and its … Type: | 8 | 1 | 6 | 494 |
 | QUANTA MEDICAL [Automatic translation follows] 33 years of clinical research in Pharma, Medical Device & Dermo-Cosmetics QUANTA MEDICAL Shared experience CRO since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, food, dermatology, cosmetics and medical device industries, 30 years of expertise in Human Health reinforced by: - double ISO 9001 & 27001 - dedicated technical tools (QUANTA VIEW®, E-CRF, Trial-On-Line®) Clinical Research / Clinical Trial, e-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT Development, Health Risk Assessment, and Regulatory … Type: | 0 | 0 | 0 | 9 |
 | ASTRUM CRO France (formerly POPSI CUBE) Agile Clinical & Digital Pan European Contract Research Organization (CRO) We are a Pan European Clinical Contract Research Organization (CRO), We offer to our Pharmaceutical, Biotech and Medtech partners a complete outsourcing of their clinical trials from phase I to phase IV by integrating the entirety of the value creation chain of medical product development activity. The origin of Popsi Cube is a convergence between a solid clinical process and effective IT tools. A CRO with integrated tools to address the entire clinical research functional scope. A successful project management requires top quality human resources but also a set of … Type: | 0 | 0 | 0 | 23 |
 | BioSpeedia BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur. BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, … Type: | 1 | 1 | 0 | 3 |
 | AKTEHOM [Automatic translation follows] An Ambition for Life At the crossroads of scientific expertise and regulatory advice, AKTEHOM supports pharmaceutical and biotechnology manufacturers in the control and understanding of products and processes with an objective of quality and performance to guarantee patient safety. AKTEHOM has a strong identity, focused on customer relations and the well-being of its employees, which is added to proven expertise. The pleasure of bringing value to our clients, carrying out their projects and succeeding together guides our team of 50 people on a daily basis. AKTEHOM intervenes in particular in the following areas: - Product/Precedence Mastery: implementation … Type: | 9 | 1 | 8 | 58 |
 | Takodana Pt Takodana Portugal is a medical grade Cannabis production company, operating in Portugal. Pharmabis Medical is a medical grade Cannabis production company, operating in Portugal in compliance with state and UE laws. With a focus on the cultivation of high quality cannabis, it is supported by high tech solutions and an experienced team. We work with local and international partners to research and develop new techniques and quality genetics, with the goal of providing our clients with the finest pharmaceutical ingredients. Type: | 0 | 0 | 0 | 6 |
 | Grifols Innovating for patients and society Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, … Type: | 3 | 2 | 1 | 10,773 |
 | Canopy Growth Corporation Unleashing the power of cannabis to improve lives Canopy is a world leading cannabis company focused on unleashing the power of cannabis to improve lives. From supporting personal wellness to fostering economic opportunity and striving towards social justice, Canopy is showcasing the capacity of cannabis as a force for good. Type: | 1 | 0 | 1 | 830 |
 | Francelab [Automatic translation follows] At FranceLab we are dedicated to manufacturing medicines with the highest quality standards. Francelab is a national pharmaceutical company dedicated exclusively to oral hypoglycemic medications. Located in the Tigre industrial park. Our Vision: To become a company with a national presence that achieves commercial results based on quality, friendship and communication with doctors, patients, social works and distribution channel. Our Mission: Produce medicines and relationships that exceed the quality standard Our commitment: Is to promote and maintain a culture of respect. We do not discriminate based on gender, religion, ethnicity, nationality, culture, social group, disability, illness, sexual … Type: | 0 | 0 | 0 | 29 |
 | Polepharma La Fabrique [Automatic translation follows] The French (bio)pharmaceutical industrial sector. Pharmaceutical industry and Healthcare industry Type: | 14 | 4 | 13 | 3 |
 | Giphar [Automatic translation follows] Let's take your health to heart Created in 1968, Giphar (Independent Group of Independent Pharmacists) is the leader in under-brand pharmacy networks on the French market. Giphar in figures: • 1,250 pharmacies, 1,800 pharmacists • 1st pharmacy brand in France according to the latest LSA ranking • 2.3 billion euros in turnover • 5 pharmaceutical statuses: Wholesaler Distributor, Depositary, Pharmaceutical Laboratory, Pharmaceutical Purchasing Center and Medicine Broker • 4 warehouses: Grandvilliers (60), Castelaneau-le-lez (34), Angers (49) and Dijon (21) • 2 brands: Libeoz (medical equipment for autonomy and mobility), Laboratoire Giphar (para-pharmacy) But Giphar is also men … Type: | 8 | 1 | 6 | 382 |
 | Farmindustria | 4 | 2 | 0 | 214 |
 | ASW Do you need qualified researchers and scientists in specific areas? Or for longer or shorter periods of time? Do you need to find a solution enabling you to outsource co-workers whom you still want to continue collaborating with? We match staffing solutions so that they correspond to our customers' expectations as regards quality, efficiency, speed, cost and service. When providing staffing services, we identify the most qualified and motivated co-workers and match them to our customers' need. | 1 | 0 | 0 | 161 |
 | Altana | 1 | 1 | 0 | 116 |
 | Le Comptoir Des Pharmacies [Automatic translation follows] Together, let's simplify your management 💊 Le Comptoir des Pharmacies 💊 is the first web platform that strengthens the financial health of pharmacies to sustain the territorial network, while preserving the environment 🌿 Our marketplace is direct, digital and innovative access to all their supply channels (laboratories, purchasing centers, colleagues), without market constraints, delivered quickly, at the right price, all year round. Specializing in inventory and purchasing management, we have been supporting pharmacies since 2016 by enabling them to avoid wasting medications while sourcing without constraints on range or volume. The Comptoir des Pharmacies is: 👨⚕️ 10,500 … | 1 | 0 | 1 | 40 |
 | Leadersanté [Automatic translation follows] Leadersanté, the success accelerator for pharmacists. The Leadersanté Group is a network of pharmacies located throughout France and in the French Overseas Territories. Our Leadersanté brands as well as our layout concept with our distinct and identifiable universes have made us a leader in the world of services and advice with a large network of pharmacies (more than 900 pharmacies to date). Are you an independent pharmacy, do you want to develop your business and stimulate your growth? Don’t wait any longer, give your pharmacy the brand and concept it deserves. Leadersanté is the only group to … Type: | 1 | 0 | 0 | 74 |
 | Europhartech [Automatic translation follows] DOMES PHARMA MANUFACTURING Production site of the Dômes Pharma Group EUROPHARTECH is also CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specializing in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator, hospital ATU/AMM and unit EHPAD BUD, PDA, generic and nutraceutical markets. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group, historically specialized in Animal Health and present in Human Health since 1992. Laboratory approved by … Type: | 2 | 1 | 0 | 73 |
 | Indicia [Automatic translation follows] Industrial microbiology - Rapid microbiology - Aseptic formulation and packaging At the heart of our business: sterility A French company within the Protex International group, our historical know-how is the manufacture of sterile liquid products. A trusted partner of Pharma, Diagnostics, Cosmetics and Biotech manufacturers, Indicia offers industrial production services to companies wishing to outsource the formulation, sterilization and packaging of liquid or semi-liquid reagents. This expertise includes in particular the subcontracted production of culture media for Microbiology. Drawing on this expertise, Indicia markets its own range of media for traditional microbiological controls (broths, agars) and offers … Type: | 0 | 0 | 0 | 28 |
 | GIE GERS - Groupement pour l'Elaboration et la Réalisation de Statistiques [Automatic translation follows] The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. The GIE GERS is an economic interest group created by companies in the Pharmaceutical Industry. For 45 years, GERS has supported its members in market analysis and performance management and offers unique comprehensive data by pooling data on medicines and health products. GERS plays a key role in the conventional system and economic regulation of reimbursable and hospital medicines. Sell In data is used by health authorities to monitor key market indicators, determine the drug pricing policy based on the level of … Type: | 15 | 3 | 11 | 8 |
 | Fédération Française des Industries de Santé - FEFIS [Automatic translation follows] The ambition to put its action at the service of public health policy, a source of social and economic progress. Created in 1975, the French Federation of Health Industries – Féfis – brings together eleven professional organizations representing companies which create, manufacture or distribute health products such as human and veterinary medicines, medical devices, optical products, dental products, in vitro diagnostics. A crossroads for exchanges and common actions, Féfis strives to be the spokesperson for a strategic sector of the future for the growth and competitiveness of our country. His commitments within numerous structures – ARIIS, MEDEF, … Type: | 26 | 6 | 21 | 6 |
 | Kern Pharma [Automatic translation follows] Our mission for 25 years is to take care of people's health with an eye toward the future and innovation. Kern Pharma is a privately held pharmaceutical company that belongs to the Indukern Group and has its own commercial activities in the ethical and hospital field with both generic and branded products. Furthermore it is a reliable partner for contract manufacturing activities for important players of the pharmaceutical market. Kern Pharma is the pharmaceutical company of the Indukern Group. It bases its activity around two strategic business axes: - The development, manufacturing and marketing of pharmaceutical products … Type: | 4 | 0 | 0 | 834 |
 | Crossject Expert des médicaments d'urgence auto-administrés Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal … Type: | 16 | 7 | 1 | 94 |
Corporate subsidiary